540 likes | 825 Views
Diabetes 2012: Pump, Sensors, Current Medical Therapy & Future Dreams. Shannon Kelley Oates MD February 2012. Diabetes Introduction. Why we need to consider the impact How large is the problem? How can you understand what it is to be a person with diabetes?. Diabetes Mellitus. Type 1
E N D
Diabetes 2012: Pump, Sensors, Current Medical Therapy & Future Dreams Shannon Kelley Oates MD February 2012
Diabetes Introduction Why we need to consider the impact How large is the problem? How can you understand what it is to be a person with diabetes?
Diabetes Mellitus Type 1 Rare—affecting only 1 in 250 (1 in 400 kids) 15,000 new cases per year Low rates in Black and Asian populations Type 2 Common Probably 25 million cases in the US. 1/3 cases undiagnosed Projected prevalence of 11% WOW! Over age 65, 27% with DM Cost: $ 218 billion in 2007
Diabetes MellitusType 1 and Mortality Mortality rates for people with DM Type 1 are 5 to 7 times the general population More than 15% of people with DM type 1 will die by age 40 They die of DKA, of renal failure, of cardiovascular disease Life expectancy is reduced by 15 years
Competence Questions 1. What are the indications for an insulin pump? a. desire for a pump and insulin use b. diabetes type 1 if on Medicare c. diabetes type 2 for many commercial insurances d. Insulin use
Competence Questions 2. Name 3 new diabetes therapies in the last few years a. Exenetide, bromocriptine, glimepiride b. Bromocriptine, linagliptin, saxagliptin c. Carbohydrate counting, continuous glucose monitoring, insulin pumps
Competence Questions 3. Continuous glucose monitoring can be used a. only with a pump b. only with multidose injection insulin therapy c. must be used daily d. costs about $35 per week on-going costs
Take Home Goals Think like a pancreas Give enough insulin Get and give loads of education
Insulin Secretion- Physiology 70 Serum insulin 50 Insulin (mU/L) 30 10 0 9:00 am 9:00 pm 12:00 am 3:00 am 6:00 am 12:00 pm 3:00 pm 6:00 pm Time of Day Lunch Dinner Breakfast Polonsky, N Engl J Med 1996; 334: 777-783
Insulin Secretion- Physiology 70 Serum insulin 50 Insulin (mU/L) 30 10 0 9:00 am 9:00 pm 12:00 am 3:00 am 6:00 am 12:00 pm 3:00 pm 6:00 pm Time of Day Skips Lunch BiggerDinner Breakfast Polonsky, N Engl J Med 1996; 334: 777-783
Intensive Therapy Decreases risks of microvascular disease Retinopathy 75% reduction Nephropathy 50% reduction Neuropathy 60% reduction Goal is to achieve normoglycemia Measure BS frequently Increases risk of hypoglycemia
Insulin Time-Action Patterns Normal Insulin Secretion at Meal Time Regular insulin NPH Insulin Premix 70/30 Change in Serum Insulin Baseline Level Time (hours) s.c. Injection
Insulin Time-Action Patterns Normal Insulin Secretion at Meal Time Regular insulin NPH Insulin Premix 70/30 Change in Serum Insulin Baseline Level Time (hours) s.c. Injection
Insulin Aspart Pro Asp Phe Gly Arg Phe Tyr Glu B20 Thr Gly Asp Cys Lys B28 B30 Thr A21 Asn Cys Val Tyr Leu Gly A1 Asn Tyr Ile Glu Leu Val Leu Ala Glu Gln Glu Gln Tyr Val Cys Leu Cys Ser Thr Ser Ile Leu Cys His Ser Gly Cys Leu B1 Phe Val Asn Gln His
Normal Insulin Secretion 70 Serum insulin 50 Insulin (mU/L) 30 How can we approach this ideal? 10 0 9:00 am 9:00 pm 12:00 am 3:00 am 6:00 am 12:00 pm 3:00 pm 6:00 pm Time of Day Lunch Dinner Breakfast Polonsky, N Engl J Med 1996; 334: 777-783
Insulin Regimens Twice a day mixed insulin Once daily long acting with lispro or regular with each meal Twice daily intermediate or long acting insulin with lispro or regular at each meal Once a day long acting insulin with lispro/aspart/glulisine at each meal CSII is continuous subcutaneous insulin infusion this is insulin pump
Insulin Pen or Syringe Injections with MDI can approach the Ideal Insulin pens are very handy Use ONLY on one person
CSII or Insulin Pump Programmed basal rate of insulin and calculated boluses with carbohydrate intake Place needle or catheter subcutaneously every 3 days Short or rapid insulin analog only Special attention to prevent DKA
Insulin Pumps Call 1-800 Number if ?? Accu-Chek Omnipod Medtronic MiniMed Animas Deltec
Future? Insulin Pumps Old pumps Animas Accu-Chek Omnipod Deltec Tandem Spring Zone
Pump Manufacturers MiniMed www.minimed.com Several pumps Great support Animas www.animas.com Implantable monitor in testing phase Omnipod No tubing www.myomnipod.com
Way Cool A 15 year old can sleep in until noon on the weekend and not get up and take an injection and eat breakfast Indications? Desire for a pump Some understanding of the limitations of the technology
Need to know the glucose Call 1-800 Number if ??
Newer Meters iPhone App- Wavesense Iphone add-on meter iBGStar Bayer USB meter Call 1-800 Number if you have ?? 4/2/2014 28
Continuous Monitoring 4/2/2014 29
Patient versions of Continuous Monitoring or CGM Dexcom 7 Medtronic Real time or Guardian
Two Versions of CGM • Professional • If we need more information, we can do the “Holter Monitor” of glucose • Several days of glucose data with meals and insulin data from the patient • Personal • The patient sees the glucose data as it is produced • Can be used continuously or intermittently • Cost about $35 cash per usage 4/2/2014 31
Two Versions of CGM Professional-- called iPro 4/2/2014 32
Continuous Monitoring Software 4/2/2014 34
CGM for Patients- Receivers 4/2/2014 35
Up to 75% of severe hypoglycemic episodes in children occur at night* *Ahmet A, Dagenais S, Barrowman NJ, et al. Prevalence of nocturnal hypoglycemia in pediatric type 1 diabetes: a pilot study using continuous glucose monitoring. J Pediatrics, 2011;159 (2): 297-302.
Transplants Whole pancreas transplants usually along with kidney Technical difficulties with islet only transplants Autotransplantation of islets– only if we take out your pancreas for NON diabetes reason
Newer Classes of Antidiabetes Therapies: The Era of Incretin-based Therapies plus … Exenatide (GLP-1 receptor agonist) Liraglutide (GLP-1 receptor agonist) Sitagliptin (DPP-IV inhibitor) Saxagliptin (DPP-IV inhibitor) 2005 2006 2007 2008 2009 2010 Colesevelam (bile acid binder) Bromocriptine (dopamine agonist) 2012 Exenatide XR (GLP-1 receptor agonist) . Food and Drug Administration. accessdata.fda.gov. Accessed 25 May 2010.
Best of the Web www.diabetes.org - American Diabetes Association www.childrenwithdiabetes.com Lovely site, easy to navigate, active chat Archived expert answers Diabetes camp info www.diabetesmonitor.com www.diabetesstation.org www.jdf.org – Juvenile Diabetes Association www.2aida.net -very cool insulin simulator
Real life with Diabetes Find your ice skates Have a snack Test your blood sugar Laugh at your roomie Test, count, inject Study, sleep. Test sugar Count carbs Do a shot Go to class Test sugar, count carbs, do a shot Treat a low blood sugar
Future ? Artificial pancreas Better data collection Easier diagnosis Test genes to see who might get disease Your glucose sensor reminds you that you forgot to take insulin Scan the food for auto carb calculation Dr. Oates is on the beach with her computer and your company pays her NOT to see you
Competence Questions: Multiple right answers 1. What are the indications for an insulin pump? a. desire for a pump and insulin use b. diabetes type 1 if on Medicare c. diabetes type 2 for many commercial insurances d. Insulin use
Competence Questions: Single Best Answer 2. Name 3 new diabetes therapies in the last few years a. Exenetide, bromocriptine, glimepiride b. Bromocriptine, linagliptin, saxagliptin c. Carbohydrate counting, continuous glucose monitoring, insulin pumps
Competence Questions -True Statements 3. Continuous glucose monitoring can be used a. only with a pump b. only with multidose injection insulin therapy c. must be used daily d. can cost about $35 per week on-going costs
Take Home Goals Think like a pancreas Give enough insulin Get and give loads of education Call the 800 number on the back of any technology
THANK YOU! • oatess@iuhealth.org